| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹16,024 | +6.83% | |
| 6 months | ₹30,000 | ₹32,746 | +9.15% | |
| 1 year | ₹60,000 | ₹65,815 | +9.69% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Laurus Labs Ltd | Healthcare | Equity | 10.79% |
| Lupin Ltd | Healthcare | Equity | 8.96% |
| Fortis Healthcare Ltd | Healthcare | Equity | 7.52% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 6.68% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 5.14% |
| Alkem Laboratories Ltd | Healthcare | Equity | 5.14% |
| Biocon Ltd | Healthcare | Equity | 4.64% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.27% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.71% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.19% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.18% |
| Gland Pharma Ltd | Healthcare | Equity | 3.05% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.77% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.51% |
| Wockhardt Ltd | Healthcare | Equity | 2.47% |
| Ami Organics Ltd | Healthcare | Equity | 2.46% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 2.27% |
| Ajanta Pharma Ltd | Healthcare | Equity | 2.23% |
| Abbott India Ltd | Healthcare | Equity | 2.21% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 2.14% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 1.94% |
| Piramal Pharma Ltd | Healthcare | Equity | 1.86% |
| Global Health Ltd | Healthcare | Equity | 1.84% |
| Granules India Ltd | Healthcare | Equity | 1.83% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 1.68% |
| Natco Pharma Ltd | Healthcare | Equity | 1.26% |
| Syngene International Ltd | Healthcare | Equity | 1.12% |
| Pfizer Ltd | Healthcare | Equity | 1.12% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 1.06% |
| Poly Medicure Ltd | Healthcare | Equity | 0.99% |
| Repo | Unspecified | Repo | 0.10% |
| Net Payables | Unspecified | Net Payables | -0.13% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +8.9% | +19.9% | +20.9% | +54.9% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 18 | 11 | 10 | -- |